Abdul Mannan – VWF:RCo for Diagnosing von Willebrand Disease: That Test Might Be Failing Your Patients
Abdul Mannan, Consultant Haematologist at Betsi Cadwaladr University Health Board, shared on LinkedIn:
“Are you still using VWF:RCo to diagnose von Willebrand Disease (vWD)?
That test might be failing your patients.
Here’s the problem: VWF:RCo uses ristocetin, an antibiotic, to force an artificial interaction between VWF and platelets. It doesn’t measure how VWF actually works in the body. And it has a serious blind spot.
The D1472H gene variant is present in 63% of African Americans. This variant causes VWF:RCo to give falsely low results. Same patient. Same blood. Wrong answer. This leads to misdiagnosis based purely on genetics.
Why VWF:GPIbM is the better choice:
- It uses engineered GPIb receptors that bind VWF directly, mimicking what happens in real life
- It measures true physiological function, not an artificial reaction
- It’s unaffected by the D1472H variant
- It shows better reproducibility, especially at low VWF levels
- It’s now recommended in ASH/ISTH/NHF/WFH guidelines (Blood Advances, 2021)
Think of it this way. VWF:RCo is like checking if a key fits by looking at scratches on the keyhole. VWF:GPIbM actually turns the door handle to see if the lock works.
If your lab still reports only VWF:RCo, it might be time for a conversation with your laboratory team. Equitable diagnosis shouldn’t depend on a patient’s ethnic background.
What assay does your lab use for VWF activity?”

More posts featuring Abdul Mannan on Hemostasis Today.
-
Jul 9, 2026, 16:45Rutbaa Ayaz Shaikh: One Step Further in Medical Research
-
Jul 9, 2026, 14:49Celebrating a Century of von Willebrand Disease Research and Care – Seminars in Thrombosis and Hemostasis
-
Jul 9, 2026, 14:38Valance Washington: International Hemostasis Community Prepares for GRC 2026
-
Jul 9, 2026, 14:27Dima Shulkin: Next-Generation AI Models Improve Early Sepsis Recognition
-
Jul 9, 2026, 14:12Omar Hajji: Seasonal Determinants of Mortality in Sepsis and Cardiogenic Shock
-
Jul 9, 2026, 13:54Hussein Yassine: Why Omega-3s May Fall Short in Preventing Alzheimer’s Disease
-
Jul 9, 2026, 13:16Olivier Mathieu: Innovating the Future of Hemostasis at ISTH 2026
-
Jul 9, 2026, 12:41Thomas Palmer-Dench: Hexokinase Controls Platelet Activation and Hemostasis
-
Jul 9, 2026, 12:19Paschalis Evangelidis: Join Our Special Issue on Thrombosis and Vascular Disorders